|
Access the live webcast and webcast archive for Q2 2008 Covidien Ltd. Earnings Conference Call on Tuesday, May 6, 2008 at 7:30 AM ET. Covidien Ltd. (Covidien) is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company operates its business through four segments: Medical Devices, Pharmaceutical Products, Imaging Solutions and Medical Supplies. The Company's customers include hospitals, surgi-centers, imaging centers, alternate site facilities, drug manufacturers and major retailers worldwide. In April 2007, the Company's Medical Devices segment acquired intellectual property from Sorbx, LLC (Sorbx), which is a developer of an absorbable tack technology used in hernia repair procedures. In November 2006, the Company's Medical Devices segment acquired the remaining interest in Airox S.A. In April 2008, the Company announced that one of its subsidiaries has acquired a 91% of the outstanding shares of Tissue Science Laboratories plc. In April 2008, the Company sold its Retail Products business to an affiliate of First Quality Enterprises, Inc.
|
